the idea behind the mixed disease is that this specific autoantibody is also present in other autoimmune diseases such as systemic lupus erythematosus polymyositis scleroderma etc mctd was characterized as an individual disease in 1972 by sharp et al and the term was introduced by leroy in 1980 it is sometimes said to be the same as undifferentiated connective tissue disease but other experts specifically reject this idea because undifferentiated connective tissue disease is not necessarily associated with serum antibodies directed against the u1 rnp and mctd is associated with a more clearly defined set of signs symptoms differential diagnosis cpt2 mctd combines features of scleroderma myositis systemic lupus erythematosus and rheumatoid arthritis with some sources adding polymyositis dermatomyositis and inclusion body myositis and is thus considered an overlap syndrome the initial clinical manifestations of mctd usually are unspecific they can consist of general malaise arthralgias myalgias and fever the specific signs to suspect this disease is the presence of positive antinuclear antibodies ana specifically anti rnp associated with raynaud s phenomenon almost every organ can be affected by mctd raynaud s phenomenon is the most common presenting symptom seen in patients with arthralgia and swollen hands being the second